Delivery Order SPE2DB20D3103-SPE2DB24FL7A4
Award Date
11/29/23
Potential Completion Date
11/30/23
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,371.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV5YX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,104.10 firm-fixed-price delivery order is for the pharmaceutical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award, with ID SPE2DB24D2003|SPE2DB25FXFJ3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $1,155.20 and a completion date of February 26, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,575.18, is for the delivery of the medication XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 6, 2024. This contract is not associated with a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, with a ceiling value of $2,716.10 and a completion date of December 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,174.55 and provides for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total value of $999,999,999 and runs...
This federal contract award, with ID SPE2DB24D3015|SPE2DB24FFXUE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,642.47 firm fixed-price delivery order is for the supply of 4565821810 XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a prescription medication. The contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award, valued at $4,855.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The contract, valued at $1,553.03, was awarded by the Defense Logistics Agency (DLA) on December 6, 2024, with a completion date of December 9, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
This federal contract award, with an ID of SPE2DB20D3103 and SPE2DB24FP4G3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,575.18, is for the delivery of the drug XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract is a Firm Fixed Price Delivery Order, with a completion date of July 8, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...